CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 928358-928502 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T97572","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusion: CRMP5 antibodies were detected in approximately 8% of the SCLC and 11% of the thymoma patients by the ITT immunoprecipitation assay."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T167","span":{"begin":0,"end":144},"obj":"Sentence"}],"text":"Conclusion: CRMP5 antibodies were detected in approximately 8% of the SCLC and 11% of the thymoma patients by the ITT immunoprecipitation assay."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1963","span":{"begin":70,"end":74},"obj":"Phenotype"},{"id":"T1964","span":{"begin":90,"end":97},"obj":"Phenotype"}],"attributes":[{"id":"A1963","pred":"hp_id","subj":"T1963","obj":"http://purl.obolibrary.org/obo/HP_0030357"},{"id":"A1964","pred":"hp_id","subj":"T1964","obj":"http://purl.obolibrary.org/obo/HP_0100522"}],"text":"Conclusion: CRMP5 antibodies were detected in approximately 8% of the SCLC and 11% of the thymoma patients by the ITT immunoprecipitation assay."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5804","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T5805","span":{"begin":90,"end":97},"obj":"Disease"},{"id":"T39866","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T69974","span":{"begin":90,"end":97},"obj":"Disease"}],"attributes":[{"id":"A5804","pred":"mondo_id","subj":"T5804","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A5805","pred":"mondo_id","subj":"T5805","obj":"http://purl.obolibrary.org/obo/MONDO_0006456"},{"id":"A51134","pred":"mondo_id","subj":"T39866","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A65787","pred":"mondo_id","subj":"T69974","obj":"http://purl.obolibrary.org/obo/MONDO_0006456"}],"text":"Conclusion: CRMP5 antibodies were detected in approximately 8% of the SCLC and 11% of the thymoma patients by the ITT immunoprecipitation assay."}